Sale!

Replica Osimertinib: Targeted EGFRm NSCLC Treatment

Original price was: $698.00.Current price is: $539.00.

Targeting NSCLC with EGFR mutations, 3rd gen irreversible EGFR-TKI, Active against CNS metastasis, Indicated for EGFR Ex19Del and EGFR L858R mutations,

SKU: SKU67EOFGHVX Category:
Guaranteed Safe Checkout

Targeting NSCLC with EGFR mutations, 3rd gen irreversible EGFR-TKI, Active against CNS metastasis, Indicated for EGFR Ex19Del and EGFR L858R mutations,

Scroll to Top